Proposal for new USP Chapter <317> ICP OES Testing for Sodium Hydroxide and Potassium Hydroxide Published for Comments
Recommendation
1/2 October 2024
Barcelona, Spain
Performance Evaluation and Monitoring for compliant Analytical Procedures and Processes
In the Pharmacopeial Forum, PF 50(3), a proposal for a new General Chapter <317> ICP OES Testing for Sodium Hydroxide and Potassium Hydroxide was published. The text was developed by the Excipients Test Methods Expert Committee (ETM EC). Commenting is open until 31 July 2024.
The briefing notes state that "the proposal contains ICP-OES methods for the determination of Content of Sodium in Sodium Hydroxide and Content of Potassium in Potassium Hydroxide. The methods are based on the validated ICP-OES methods of analysis. Similarly, for the tests related to the estimation of potassium as an impurity in Sodium Hydroxide and sodium as an impurity in Potassium Hydroxide, an ICP-OES-based method is being proposed."
The Chapter is applicable to the analysis of sodium hydroxide and potassium hydroxide only. In the briefing notes, it is pointed out that the chapter does not cover analysis of other related excipients. Furthermore, "the methods in this general chapter are nonmandatory and are not part of Sodium Hydroxide and Potassium Hydroxide monograph specification in the absence of a reference in the General Notices, a monograph, or another applicable general chapter numbered below 1000."
The proposal is structured as follows:
- Methods
- Content of Sodium in Sodium Hydroxide
- Content of Potassium in Potassium Hydroxide
- Potassium as an Impurity in Sodium Hydroxide - Additional Requirements
- USP Reference Standards <11>
The full text and further information are available via the USP website access point.
Related GMP News
18.09.2024USP Draft Chapter on HPTLC Identification of Fixed Oils published for Comments
11.09.2024U.S. Manufacturer Faces FDA Warning Letter for Serious Quality Failures
05.09.2024Meet the AQCG Board Members at PharmaLab 2024
05.09.2024Q&As from the Live Online Training "Introduction to the AQCG's new AIQSV Guide" - Part 2
21.08.2024FDA issues Warning to Jordanian OTC Manufacturer
14.08.2024FDA Issues Warning Letter to Vietnamese Drug Manufacturer for CGMP Violations